3D microphysiologic system
The present invention relates generally to a three-dimensional cell and tissue culture system for the female reproductive tract. In particular provided herein the system includes individual female reproductive cultures in a dynamic microfluidic setting or integrated using a microfluidic microphysiologic system. In some embodiments, the present invention provides ex-vivo female reproductive tract integration in a three dimensional (3D) microphysiologic system.
1. A microphysiologic system comprising:
(a) an ovarian follicle 3D cell culture subsystem comprising at least a first cell type in 3D culture and a culture media for said first cell type; and
(b) a fallopian tube 3D cell culture subsystem comprising at least a second cell type in 3D culture and a culture media for said second cell type;
wherein the ovarian follicle 3D cell culture subsystem and the fallopian tube 3D cell culture subsystem are in unidirectional fluid communication such that fluid from the ovarian follicle 3D cell culture subsystem flows downstream to the fallopian tube 3D cell culture subsystem.
2. The microphysiologic system of claim 1 , further comprising:
(c) a uterine 3D cell culture subsystem comprising at least a third cell type in 3D culture and a culture media for said third cell type;
wherein the fallopian tube 3D cell culture subsystem and the uterine 3D cell culture subsystem are in unidirectional fluid communication such that fluid from the fallopian tube 3D cell culture subsystem flows downstream to the uterine 3D cell culture subsystem.
3. The microphysiologic system of claim 2 , further comprising:
(d) an endocervical 3D cell culture subsystem comprising at least a fourth cell type in 3D culture and a culture media for said fourth cell type;
wherein the uterine 3D cell culture subsystem and the endocervical 3D cell culture subsystem are in unidirectional fluid communication such that fluid from the uterine 3D cell culture subsystem flows downstream to the endocervical 3D cell culture subsystem.
4. The microphysiologic system of claim 3 , further comprising:
(e) an ectocervical 3D cell culture subsystem comprising at least a fifth cell type in 3D culture and a culture media for said fifth cell type;
wherein the endocervical 3D cell culture subsystem and the ectocervical 3D cell culture subsystem are in unidirectional fluid communication such that fluid from the endocervical 3D cell culture subsystem flows downstream to the ectocervical 3D cell culture subsystem.
5. The microphysiologic system of claim 4 , wherein factors secreted from cells in the ovarian follicle 3D cell culture subsystem flow downstream to the fallopian tube, uterine, endocervical, and/or ectocervical 3D cell culture subsystems, factors secreted from cells in the fallopian tube 3D cell culture subsystem flow downstream to the uterine, endocervical, and/or ectocervical 3D cell culture subsystems, factors secreted from cells in the uterine 3D cell culture subsystem flow downstream to the endocervical and/or ectocervical 3D cell culture subsystems 3D cell culture subsystem, and factors secreted from cells in the endocervical 3D cell culture subsystem flow downstream to the ectocervical 3D cell culture subsystem.
6. The microphysiologic system of claim 1 , wherein the ovarian follicle 3D cell culture subsystem comprises one or more of granulosa cells, theca cells, and oocytes.
7. The microphysiologic system of claim 6 , wherein the ovarian follicle 3D cell culture subsystem comprises one or more ovarian follicles in 3D culture.
8. The microphysiologic system of claim 7 , wherein the ovarian follicles are polymer-encapsulated.
9. The microphysiologic system of claim 8 , wherein the polymer comprises alginate.
10. The microphysiologic system of claim 7 , wherein the ovarian follicles remain viable for at least one simulated menstrual cycle.
11. The microphysiologic system of claim 7 , wherein the ovarian follicles respond to FSH and hCG stimulation by producing estrogen and progesterone in a pattern that mimics the human menstrual cycle.
12. The microphysiologic system of claim 11 , wherein said estrogen and progesterone pass by unidirectional fluid communication to the fallopian tube 3D cell culture subsystem.
13. The microphysiologic system of claim 12 , wherein cells of the fallopian tube 3D cell culture subsystem respond to said estrogen and/or progesterone with one or more of cilliary beating, increased oviductal glycoprotein 1 (OVGP1) expression, and cilliary beat frequency (CBF) and/or insulin-like growth factor 1 (IGF1) secretion.
14. The microphysiologic system of claim 1 , wherein the fallopian tube 3D cell culture subsystem comprises one or both of secretory epithelial cells and ciliated epithelial cells.
15. The microphysiologic system of claim 14 , wherein the fallopian tube 3D cell culture subsystem comprises fallopian epithelium tissue pieces grown on media-permeable cell supports.
16. The system of claim 14 , wherein the fallopian tube system remains viable and maintains both secretory and ciliated epithelium cell phenotypes for at least one simulated menstrual cycle.
17. The microphysiologic system of claim 1 , wherein the uterine 3D cell culture subsystem comprises one or more of endometrial epithelial cells, endometrial stromal cells, myometrial smooth muscle cells, and myometrial fibroblast cells.
18. The microphysiologic system of claim 1 , wherein the endocervical 3D cell culture subsystem comprises one or both of endocervical epithelial cells and endocervical stromal cells.
19. The microphysiologic system of claim 1 , wherein the ectocervical 3D cell culture subsystem comprises one or both of ectocervical epithelial cells, J2-3T3 fibroblasts, and ectocervical stromal cells.
20. The microphysiologic system of claim 1 , comprising a microfluidic component that provides said unidirectional fluid communication.
21. A microphysiologic system comprising:
(a) an ovarian follicle 3D cell culture subsystem comprising granulosa cells, theca cells, and/or oocytes in 3D culture;
(b) a fallopian tube 3D cell culture subsystem comprising secretory epithelial cells and/or ciliated epithelial cells in 3D culture;
(c) a uterine 3D cell culture subsystem comprising endometrial epithelial cells, endometrial stromal cells, myometrial smooth muscle cells, and/or myometrial fibroblast cells in 3D culture;
(d) an endocervical 3D cell culture subsystem comprising endocervical epithelial cells and/or endocervical stromal cells in 3D culture; and
(e) an ectocervical 3D cell culture subsystem comprising ectocervical epithelial cells, J2-3T3 fibroblasts, and/or ectocervical stromal cells in 3D culture;
wherein the ovarian follicle 3D cell culture subsystem and the fallopian tube 3D cell culture subsystem are in unidirectional fluid communication such that fluid and factors from the ovarian follicle 3D cell culture subsystem flow downstream to the fallopian tube 3D cell culture subsystem;
wherein the fallopian tube 3D cell culture subsystem and the uterine 3D cell culture subsystem are in unidirectional fluid communication such that fluid and factors from the fallopian tube 3D cell culture subsystem flow downstream to the uterine 3D cell culture subsystem;
wherein the uterine 3D cell culture subsystem and the endocervical 3D cell culture subsystem are in unidirectional fluid communication such that fluid and factors from the uterine 3D cell culture subsystem flow downstream to the endocervical 3D cell culture subsystem;
wherein the endocervical 3D cell culture subsystem and the ectocervical 3D cell culture subsystem are in unidirectional fluid communication such that fluid and factors from the endocervical 3D cell culture subsystem flow downstream to the fourth ectocervical 3D cell culture subsystem.